Search Results

Your search for Suresh S. Ramalingam, MD matches 52 pages

Showing 51 - 52

By Jo Cavallo / Tuesday, March 25, 2014 12:44 PM

Long-Term Use of Valproic Acid May Reduce the Risk of Head and Neck Cancer

The antiseizure medication and mood stabilizer valproic acid was associated with a significant reduction in head and neck cancer risk, according to a study recently published in Cancer. The large retrospective cohort study by Kang et al was conducted to evaluate the effects of the drug, a histone...

lung cancer

By The ASCO Post Staff / Friday, June 7, 2013 12:22 PM

ASCO 2013: Novel Heat Shock Protein Inhibitor Effective in Combination with Docetaxel as Second-line Therapy for Advanced Lung Cancer

A large randomized phase II study, GALAXY-1, found that a novel heat shock protein (Hsp) 90 inhibitor, ganetespib, when combined with docetaxel in second-line therapy, leads to longer overall survival compared to standard second-line docetaxel alone in patients with advanced lung adenocarcinoma...

May

Today In Oncology

Search Results

Your search for Suresh S. Ramalingam, MD matches 52 pages

Long-Term Use of Valproic Acid May Reduce the Risk of Head and Neck Cancer

ASCO 2013: Novel Heat Shock Protein Inhibitor Effective in Combination with Docetaxel as Second-line Therapy for Advanced Lung Cancer

Ablative Radiation Therapy for Resectable Pancreatic Ductal Adenocarcinoma

Patterns in Oncology Drug Use After Accelerated Approval Is Withdrawn

Collaborative Strategy Involving AI Human Task Sharing Could Help Minimize Mammogram Costs

FDA Approves Doublet for KRAS-Mutated, Recurrent, Low-Grade Serous Ovarian Cancer

Breast Cancer Radiotherapy 1- vs 3-Week Course